From Misdiagnosis to Clarity: Lance Bass on Living with Diabetes and CGM

Episode overview

Lance Bass discusses an honest look at misdiagnosis, diabetes stigma, and how real-time continuous glucose monitoring (CGM) transformed his life on this special episode of Real-Time Real Talk recorded live at the American Diabetes Association conference (ADA) in June 2025.

When Lance was first diagnosed with type 2 diabetes, it didn’t make sense - he ate well, exercised, and didn’t fit the typical profile. But as his glucose remained high and symptoms worsened, he discovered he actually had LADA (Latent Autoimmune Diabetes in Adults), a slow-progressing form of type 1 diabetes.

Host Cher Pastore, MS, RD, CDCES, BC-ADM sits down with Lance to unpack his journey from misdiagnosis to managing his condition with CGM and advanced diabetes technology.

Lance shares how CGM with the Dexcom G7 transformed his diabetes management, allowing him to see glucose levels in real time, avoid dangerous lows, and personalize his food and insulin decisions. They discuss everything from automated insulin delivery systems to blood sugar monitoring tips, glucose sensors, and the mental relief that comes from not having to guess what’s happening in your body.

He also opens up about raising awareness, reducing stigma for young people with diabetes, and why showing his G7 publicly has helped others feel seen and supported.

This guest is a paid spokesperson for Dexcom.  Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.  Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.  Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility.  “Dexcom" refers to the Dexcom CGM.  Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7.  The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy.  G7 15 Day is only for adults 18+.

Lance Short 2 Landscape

 

 

For a deeper dive on this topic, visit GlucoseTech

GlucoseTech

To advance clinical knowledge and patient outcomes by providing evidence-based, clinically relevant CGM education that fits into real world practice.

Built by clinicians and healthcare educators, GlucoseTech delivers practical, evidence-based guidance you can apply immediately—without logins, paywalls, or barriers.

Learn More

Image
GT Image
Image
Glucose Tech

Expert insights for smarter CGM use

The GlucoseTech Podcast is a trusted educational resource for healthcare professionals seeking the latest insights in CGM technology. Featuring conversations with leading experts, episodes explore emerging evidence, practical patient management strategies, technology innovations, and real-world clinical experiences shaping the future of care. Designed for busy clinicians, GlucoseTech delivers concise, relevant discussions that help translate science into practice. Listen now to stay current on CGM technology.

  • Listen on spotify
  • Listen on Podcasts
  • Glucose tech
Dexcom healthcare provider

Request a representative visit or G7 15 Day or G7 samples

CGM=continuous glucose monitoring.

MAT-15648